CR Pharma IPO - Valuation Is Rich at the Top End
CR Pharmaceutical Group (3220 HK) plans to raise US$1,932mm - US$2,321m in its IPO through selling 1,774.6m primary shares.Our fellow insight...
283 Views
Falling Fertility Adds to China's Population Woes
By allowing couples to have up to two children China hopes to reverse its likely population decline. But falling fertility and the pressures of...
4.1k Views
Iran Shows China the Way on Population Expansion
Faced with dramatically falling birth rates, Iran has introduced a wide range of pro-natalist policies. In contrast, China has been half-hearted in...
211 Views
CR Pharma Listing: Part 3
China Resources Pharmaceutical Group has filed an Application Proof to list on the HKEX this year, possibly in the current quarter. Our previous...
340 Views
CR Pharma Listing: Part 2
China Resources Pharmaceutical Group has filed an Application Proof to list on the HKEX this year, possibly in the current quarter. Our initial...
247 Views